STOCK TITAN
  1. Home
  2. Sec-filings
  3. AGX
  4. [Form 4] ARGAN INC Insider Trading Activity

New option and RSU grants for Argan (AGX) executive Charles Collins

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Argan Inc. granted equity awards to Charles Edwin Collins IV, Chief Executive Officer of Gemma. On April 8, 2026, he received 10-year options for 332 shares of common stock at an exercise price of $588.28 per share, vesting ratably over three years starting April 8, 2027.

He was also granted 231 time-based RSUs that vest in three equal annual installments from April 8, 2027. In addition, he received performance-based RSUs with a target of 170 shares tied to three-year relative total stock return versus 12 peers, and EPS-based RSUs with a target of 2,618 shares tied to compounded EPS growth over fiscal 2027–2029.

Positive

  • None.

Negative

  • None.
Insider Collins Charles Edwin IV
Role CHIEF EXECUTIVE OFFICER, GEMMA
Type Security Shares Price Value
Grant/Award Option to Purchase Common Stock 332 $0.00 --
Grant/Award Time Based Restricted Stock Units 231 $0.00 --
Grant/Award Performance Based Restricted Stock Units 170 $0.00 --
Grant/Award Earnings Per Share Performance Based Restricted Stock Units 2,618 $0.00 --
Holdings After Transaction: Option to Purchase Common Stock — 15,067 shares (Direct); Time Based Restricted Stock Units — 6,564 shares (Direct); Performance Based Restricted Stock Units — 2,670 shares (Direct); Earnings Per Share Performance Based Restricted Stock Units — 10,118 shares (Direct)
Footnotes (1)
  1. On April 8, 2026, the Reporting Person received 10-year options to purchase 332 shares of the Issuer's common stock with an exercise price of $588.28 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/8/2027. On April 8, 2026 the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 231 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/8/2027. On April 8, 2026, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 170 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2026 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 170 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period. On April 8, 2026, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 2,618 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2027, 2028 and 2029 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026. The pay-out ratio of the target number of 2,618 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.
Stock options granted 332 options at $588.28/share 10-year options granted April 8, 2026, vest over three years
Time-based RSUs granted 231 RSUs TRSUs vest in three equal installments starting April 8, 2027
TSR performance RSUs target 170 RSUs (0–200% payout) Tied to three-year total stock return vs 12 peers
EPS performance RSUs target 2,618 RSUs (0–200% payout) Based on EPS sums for FY 2027–2029 vs FY 2024–2026
Options held after grant 15,067 options Total stock options following April 8, 2026 grant
Time-based RSUs held after grant 6,564 RSUs Total TRSUs following April 8, 2026 grant
Performance RSUs held after grant 2,670 RSUs Total PRSUs following April 8, 2026 grant
EPS performance RSUs held after grant 10,118 RSUs Total EPSRSUs following April 8, 2026 grant
Restricted Stock Units financial
"Time-Based Restricted Stock Units ("TRSUs") covering 231 shares of common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Performance-Based Restricted Stock Units financial
"Performance-Based Restricted Stock Units ("PRSUs") in the target number of 170 shares, the vesting of which is subject to the rank of the Total Stock Return"
Performance-based restricted stock units are a type of employee equity award that converts into company shares only if predefined financial or operational targets are met over a set period. Think of it like a bonus check that becomes stock only when specific goals are hit; it ties pay to results, aligning managers’ incentives with shareholders. Investors care because these awards affect future share count, executive incentives, and signal how management’s success will be measured and rewarded.
Total Stock Return financial
"subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period"
Total stock return measures the complete gain or loss an investor gets from owning a share over a set period, combining changes in the stock price with any cash payouts such as dividends, and is usually shown as a percentage. It matters because it gives a fuller picture of performance than price alone—like comparing a car’s change in resale value plus the money you earned by renting it out—to help investors compare and evaluate investments.
Earnings Per Share financial
"subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2027, 2028 and 2029"
Earnings per share represent the amount of profit a company makes for each share of its stock, similar to how a pie’s total size can be divided into slices for each person. It helps investors understand how profitable the company is on a per-share basis, making it easier to compare its performance over time or against other companies. Higher earnings per share generally indicate better profitability and can influence a company's stock value.
compounded growth EPS financial
"compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Collins Charles Edwin IV
(Last)(First)(Middle)
C/O ARGAN, INC.
4075 WILSON BLVD, SUITE 440
(Street)
ARLINGTON VIRGINIA 22203
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CHIEF EXECUTIVE OFFICER, GEMMA
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/08/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to Purchase Common Stock$588.2804/08/2026A332(1)04/08/202704/08/2036Common Stock332$015,067D
Time Based Restricted Stock Units$004/08/2026A231 (2) (2)Common Stock231$06,564D
Performance Based Restricted Stock Units$004/08/2026A170 (3) (3)Common Stock170$02,670D
Earnings Per Share Performance Based Restricted Stock Units$004/08/2026A2,618 (4) (4)Common Stock2,618$010,118D
Explanation of Responses:
1. On April 8, 2026, the Reporting Person received 10-year options to purchase 332 shares of the Issuer's common stock with an exercise price of $588.28 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/8/2027.
2. On April 8, 2026 the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 231 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/8/2027.
3. On April 8, 2026, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 170 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2026 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 170 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.
4. On April 8, 2026, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 2,618 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2027, 2028 and 2029 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026. The pay-out ratio of the target number of 2,618 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.
/s/ Charles E. Collins IV04/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What equity awards did Argan (AGX) grant to Charles Edwin Collins IV?

Argan granted Collins options on 332 shares, 231 time-based RSUs, 170 performance-based RSUs, and 2,618 EPS performance-based RSUs. These awards are part of his equity compensation and vest over multi-year periods tied to time and performance conditions.

How do the new stock options for Argan (AGX) executive Collins work?

Collins received 10-year options to purchase 332 Argan common shares at $588.28 per share. The options vest ratably over three years, with one-third vesting on each anniversary of the April 8, 2026 grant date starting April 8, 2027, if service conditions are met.

What are the terms of the time-based RSUs granted by Argan (AGX)?

Collins was granted 231 time-based restricted stock units covering Argan common shares. These TRSUs vest in three equal annual installments on each of the next three anniversaries of the April 8, 2026 grant date, beginning April 8, 2027, contingent on continued service.

How are the performance-based RSUs for Argan (AGX) executive Collins structured?

He received performance-based RSUs with a target of 170 shares, linked to Argan’s total stock return over three years versus 12 peer companies. The payout ratio ranges from 0% to 200% of the target, based on the final TSR ranking at the end of the performance period.

How will Collins’ EPS-based RSUs from Argan (AGX) vest?

Collins’ 2,618 EPS performance-based RSUs vest based on the sum of earnings per share for fiscal 2027, 2028 and 2029 compared with target compounded EPS growth derived from fiscal 2024–2026. The payout can range from 0% to 200% of the 2,618 target shares.

What are Collins’ derivative holdings after these Argan (AGX) grants?

Following the grants, Collins holds 15,067 options to purchase common stock, 6,564 time-based RSUs, 2,670 performance-based RSUs, and 10,118 EPS performance-based RSUs. These totals reflect cumulative derivative holdings of each award type after the April 8, 2026 transactions.